2
L. Annunziata et al. / Journal of Molecular Catalysis A: Chemical 337 (2011) 1–8
H502 viscometer (Viscotek,), a refractive detector and a DM400
data manager. The measurements were recorded at 150◦ using
1,2,4-trichlorobenzene as solvent and narrow molecular weight
distribution polystyrene standards as reference. Some GPC mea-
surements were performed on Waters GPC-V200 RI detector at
135 ◦C using 1,2-dichlorobenzene as solvent and Styragel columns
(range 107–103). Every value was the average of two indepen-
dent measurements. Polymer melting points (Tm) were measured
by differential scanning calorimetry (DSC) using a DSC 2920 TA
instrument in nitrogen flow with a heating and cooling rate of
10 ◦C min−1. Melting temperatures were reported for the second
heating cycle.
(50 ml) at 0◦ C, was added dropwise a solution of trimethylalu-
minium (23.6 mmol) in toluene (20 ml). The mixture was stirred
for 30 min at 0 ◦C, then warmed to room temperature and stirred
overnight. The reaction was quenched by adding a sodium hydrox-
ide water solution. The organic phase was separated, while the
aqueous phase was extracted with chloroform (2× 50 ml). The
organic phases were combined, dried over MgSO4 and the solvent
was removed by rotary evaporation. The crude product was dried
in vacuum resulting in a pale yellow powder (2.24 g, 96%).
1H NMR (CDCl3, 400 MHz, 298 K): ı 1.53 (d, J = 6.8 Hz, 3H, –CH3),
4.63 (q, 2H, –CH), 4.56 (br s, 1H, NH), 6.55 (d, J = 7.9 Hz, 2H, ArH), 6.58
(t, J = 7.6 Hz, 1H, ArH), 7.17 (m, 3H, ArH), 7.42 (d, J = 7.9 Hz,1H, ArH),
7.64 (m, 1H, ArH), 8.58 (d, J = 4.8 Hz, 1H, o-PyH). 13C NMR (CDCl3,
100 MHz, 298 K): ı 23.43 (CH3), 54.92 (CH), 113.59, 117.60, 120.53,
122.20, 129.36, 137.11, 147.26, 149.45, 164.07 (Ar–C).
2.2. Synthesis of the ligands and of the complexes
Anal. found (calcd.) for C13H14N2 (%): C, 78.72 (78.75); H, 7.05
(7.12); N, 14.16 (14.13).
N-((pyridin-2-yl)methyl)aniline (1). To a solution of 2-pyridine-
carboxaldehyde (1.50 g, 14 mmol) and aniline (1.49 g, 16 mmol) in
Complex 1a. 0.500 g of ligand 1 (2.7 mmol) were dissolved
in 20 ml of benzene. To this solution was added dropwise
a toluene solution (5 ml) of tetrakis(dimethylamido)zirconium
(0.362 g, 1.35 mmol). The resulting dark solution was stirred for 1 h
at room temperature. The solvent was then distilled off in vacuo
and the resulting powder washed twice with hexane (2× 5 ml). The
complex was recrystallized from toluene (0.652 g, 88%).
1H NMR (CDCl3, 400 MHz, 298 K): ı 2.80 (s, 6H, –N(CH3)2),
4.60 (AB pattern, J = 19.1 Hz, 2H, –CH2), 6.66 (t, J = 7.1 Hz, 1H, ArH),
7.00–7.24 (m, 6H, ArH), 7.61 (t, J = 7.8 Hz, 1H, ArH), 8.16 (d, J = 4.8 Hz,
1H, o-PyH). 13C NMR (CDCl3, 100 MHz, 298 K): ı 44.47 (N(CH3)2),
59.47 (CH2), 115.78, 116.99, 121.51, 121.89, 128.82, 129.25, 137.73,
148.10, 156.78, 164.39 (Ar–C).
´
˚
toluene (100 ml), containing 3 A molecular sieves, was added p-
toluenesulfonic acid (200 mg) at room temperature. The resulting
solution was refluxed for 18 h. After filtration, the solvent was
fied from dichloromethane/hexane obtaining a dark yellow solid
(2.19 g, 85%). Reduction of the imine function was achieved by using
NaBH3CN in methanol, following a previously reported procedure
[13], yielding the ligand as a light yellow powder (2.10 g, 95%).
1H NMR (CDCl3, 400 MHz, 298 K):ı 4.46 (br s, 2H, –CH2), 4.78
(br s, 1H, NH), 6.66 (d, J = 8.4 Hz, 2H, ArH), 6.70 (t, J = 7.4 Hz, 1H,
ArH), 7.16–7.20 (m, 3H, ArH), 7.33 (d, J = 7.8 Hz, 1H, ArH), 7.63 (t,
J = 7.8 Hz, 1H, ArH), 8.58 (d, J = 5.5 Hz, 1H, o-PyH). 13C NMR (CDCl3,
100 MHz, 298 K): ı 49.54 (CH2), 113.28, 117.83, 121.80, 122.30,
129.46, 136.82, 149.45 (Ar–C).
Anal. found (calcd.) for C28H34N6Zr (%): C, 61.34 (61.61); H, 6.18
(6.28); N, 15.19 (15.40).
Anal. found (calcd.) for C12H12N2 (%): C, 77.99 (78.23); H, 6.48
(6.57); N, 15.01 (15.21).
Complex 1b. 1b was obtained using a procedure similar to that
described for the synthesis of 1a, allowing to react 0.368 g of lig-
and 1 (2.0 mmol) and tetrakis(dimethylamido)hafnium (0.358 g,
1.0 mmol) in 10 ml of benzene (0.601 g, 95%).
N-((6-methylpyridin-2-yl)methyl)aniline (2). The imine ligand
2 was obtained using a procedure similar to that described
for the synthesis of 1, allowing to react 6-methyl-2-pyridine-
carboxaldehyde (2.30 g, 18 mmol) and aniline (1.76 g, 19 mmol)
(3.14 g, 88%). Subsequent reduction reaction with NaBH3CN gave
the amino ligand as a light brown powder (3.10 g, 98%).
1H NMR (CDCl3, 400 MHz, 298 K): ı 2.58 (s, 3H, –CH3), 4.36 (br
s, 1H, NH), 4.43 (s, 2H, –CH2), 6.65 (d, J = 8.4 Hz, 2H, ArH), 6.72 (t,
J = 7.3 Hz, 1H, ArH), 7.05 (d, J = 7.6 Hz, 1H, ArH), 7.14–7.19 (m, 3H,
ArH), 7.54 (t, J = 7.6 Hz, 1H, ArH). 13C NMR (CDCl3, 100 MHz, 298 K):
ı 24.46 (CH3), 49.38 (CH2), 113.20, 117.73, 118.75, 121.93, 129.39,
137.34, 148.01, 158.01 (Ar–C).
1H NMR (CDCl3, 400 MHz, 298 K): ı 2.74 (br s, 6H, –N(CH3)2),
4.56 (AB pattern, J = 18.0 Hz, 2H, –CH2), 6.59 (t, J = 7.3 Hz, 1H, ArH),
6.96–7.03 (m, 4H, ArH), 7.15–7.19 (t, J = 7.6 Hz, 2H, ArH), 7.54 (t,
J = 8.0 Hz, 1H, ArH), 8.15 (d, J = 5.1 Hz, 1H, o-PyH). 13C NMR (CDCl3,
100 MHz, 298 K): ı 44.37 (N(CH3)2), 59.87 (CH2), 115.93, 117.56,
121.59, 122.06, 128. 74, 137.94, 148.34, 157.17 (Ar–C).
Anal. found (calcd.) for C28H34N6Hf (%): C, 53.06 (53.12); H, 5.18
(5.41); N, 13.27 (13.19).
Complex 2a. 2a was obtained using a procedure similar to that
described for the synthesis of 1a, allowing to react 0.500 g of lig-
and 2 (2.5 mmol) and tetrakis(dimethylamido)zirconium (0.332 g,
1.25 mmol) in 15 ml of benzene (0.681 g, 95%).
Anal. found (calcd.) for C13H14N2 (%): C, 78.69 (78.75); H, 7.08
(7.12); N, 13.96 (14.13).
N-((6-bromopyridin-2-yl)methyl)aniline (3). The imine ligand
1H NMR (CDCl3, 400 MHz, 298 K): ı 2.33 (s, 3H, CH3), 3.11 (br
s, 6H, –N(CH3)2), 3.74 (d, J = 18.9 Hz, 1H, –CH2), 4.25 (d, J = 18.9 Hz,
1H, –CH2), 6.64 (t, 1H, ArH), 6.71 (d, J = 7.7 Hz, 1H, ArH), 7.01 (m,
3H, ArH), 7.22 (d, J = 7.2 Hz, 2H, ArH), 7.43 (t, J = 7.2 Hz, 1H, ArH).
13C NMR (CDCl3, 100 MHz, 298 K): ı 22.54 (CH3), 45.35 (N(CH3)2),
58.33 (CH2), 115.76, 116.78, 117.95, 122.30, 128.75, 137.32, 157.52,
159.74, 163.75 (Ar–C).
Anal. found (calcd.) for C30H38N6Zr (%): C, 62.57 (62.79); H, 6.55
(6.67); N, 14.49 (14.64).
Complex 2b. 2b was obtained using a procedure similar to that
described for the synthesis of 1a, allowing to react 0.260 g of lig-
and 2 (1.31 mmol) and tetrakis(dimethylamido)hafnium (0.232 g,
0.65 mmol) in 15 ml of benzene (0.410 g, 95%).
was obtained using
a procedure similar to that described
for the synthesis of 1, allowing to react 6-bromo-2-pyridine-
carboxaldehyde (1.2 g, 6.8 mmol) and aniline (0.67 g, 7.2 mmol).
The crude product was purified by column chromatography on
neutral alumina, using hexane/diethyl ether (1.35 g, 76%). The sub-
sequent reduction reaction with NaBH3CN gave the amino ligand
(1.07 g, 79%).
1H NMR (CDCl3, 400 MHz, 298 K): ı 4.45 (br d, 2H, –CH2), 6.62
(d, J = 7.7 Hz, 2H, ArH), 6.73 (t, J = 7.1 Hz, 1H, ArH), 7.17 (dd, 2H,
ArH), 7.30 (d, J = 7.7 Hz, 1H, ArH), 7.38 (t, J = 7.7 Hz, 1H, ArH), 7.48
(t, J = 7.6 Hz, 1H, ArH). 13C NMR (CDCl3, 100 MHz, 298 K): ı 50.44
(CH2), 113.5, 120.64, 123.6, 127.22, 139.30, 142.20, 147.5, 159.13
(Ar–C).
Anal. found (calcd.) for C12H11BrN2 (%): C, 54.59 (54.77); H, 3.81
(4.21); N, 10.68 (10.65).
N-(1-(pyridin-2-yl)ethyl)aniline (4). To a stirred solution of the
imine ligand (2.15 g, 11.8 mmol, obtained as above) in dry toluene
1H NMR (CDCl3, 400 MHz, 298 K): ı 2.37 (s, 3H, CH3), 3.14 (br
s, 6H, –N(CH3)2), 3.77 (d, J = 18.8 Hz, 1H, –CH2), 4.42 (d, J = 18.8 Hz,
1H, –CH2), 6.64 (t, J = 7.2 Hz, 1H, ArH), 6.72 (d, J = 7.7 Hz, 1H, ArH),
7.01–7.06 (m, 3H, ArH), 7.25 (m, 2H, ArH), 7.44 (t, J = 7.7 Hz, 1H,
ArH). 13C NMR (CDCl3, 100 MHz, 298 K): ı 22.51 (CH3), 45.10